CAR T Cells Contend with Myeloma in the Bone Marrow Microenvironment | Citedby Results | Blood Cancer Discovery | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

CAR T Cells Contend with Myeloma in the Bone Marrow Microenvironment

Blood Cancer Discov (2022) 3 (6): 478–480.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Deciphering the response to BCMA CAR T cell therapy

Hamza Hassan
Marco L. Davila

Nature Cancer (2024) 5 (9): 1287.

Therapeutic Effect and Adverse Event Rate of Different Treatment Methods in Patients with Multiple Myeloma and Renal Insufficiency

Lijuan Cui
Jing Ning
Rui Yang
Hainan Wang

International Archives of Allergy and Immunology (2024) 185 (7): 659.

Clinical outcomes and microenvironment profiling in relapsed/refractory multiple myeloma patients with extramedullary disease receiving anti‐BCMA CAR T‐cell‐based therapy

Yuekun Qi
Hujun Li
Kunming Qi
Feng Zhu
Hai Cheng
Wei Chen
Zhiling Yan
Depeng Li
Wei Sang
Xiaoming Fei
Weiying Gu
Yuqing Miao
Hongming Huang
Ying Wang
Tingting Qiu
Jianlin Qiao
Bin Pan
Ming Shi
Gang Wang
Zhenyu Li
Junnian Zheng
Kailin Xu
Jiang Cao

American Journal of Hematology (2024)

The landscape of novel strategies for acute myeloid leukemia treatment: Therapeutic trends, challenges, and future directions

Ri Han Wu
Chen Ying Zhu
Pei Han Yu
Yafang Ma
Liaqat Hussain
Hua Naranmandura
Qian Qian Wang

Toxicology and Applied Pharmacology (2023) 473: 116585.